Cited by 7Ferroptosis and cancer prognosisIron Metabolism and DisordersCancer-related molecular mechanisms research

Long non‐coding RNA TPT1‐AS1 inhibits ferroptosis in ovarian cancer by regulating GPX4 via CREB1 regulation

Cao, Lei, Wang, Yan, Liu, Juanni, Bai, Xiaoying, Chi, Xiaohong·2024·American Journal of Reproductive Immunology

Abstract

Background Long non-coding RNAs (lncRNAs) play crucial roles in cellular processes, with dysregulation implicated in various diseases, including cancers. The lncRNA TPT1-AS1 (TPT1 Antisense RNA 1) promotes tumor progression in several cancers, including ovarian cancer (OC), but its influence on ferroptosis and interaction with other proteins remains underexplored. Methods In this study, we employed a multi-faceted approach to investigate the functional significance of TPT1-AS1 in OC. We assessed TPT1-AS1 expression in OC specimens and cell lines using RT-qPCR, in situ hybridization (ISH), and fluorescence in situ hybridization (FISH) assays. Functional assays included evaluating the impact of TPT1-AS1 knockdown on OC cell proliferation, migration, invasiveness, and cell cycle progression. Further, we explored and validated the interaction of TPT1-AS1 with other proteins using bioinformatics. Finally, we investigated TPT1-AS1 involvement in erastin-induced ferroptosis using Iron Assay, Malondialdehyde (MDA) assay, and reactive oxygen species (ROS) detection. Results Our findings revealed that TPT1-AS1 overexpression in OC correlated with an unfavorable prognosis. TPT1-AS1 knockdown suppressed cell proliferation, migration, and invasiveness. Additionally, TPT1-AS1 inhibited erastin-induced ferroptosis, and in vivo experiments confirmed its oncogenic impact on tumor development. Mechanistically, TPT1-AS1 was found to regulate Glutathione Peroxidase 4 (GPX4) transcription via CRE…

Integrity signals

Registry

Crossref · 10.1111/aji.13864

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several transcription factors including AP-1, CREB, ATF4, and NRF2 have been shown to regulate either directly or indirectly GPX4 levels in different cellular contexts.

    “Several transcription factors including AP-1 (60, 61), CREB (62, 63), ATF4 (64), and NRF2 (45, 65, 66) have been shown to regulate either directly or indirectly GPX4 levels in different cellular contexts.”

The citation lists haven’t been fetched yet

References 63 · Cited by 7

Authors
Cao, L., Wang, Y., Liu, J., Bai, X., & Chi, X.
Affiliations
  • Xi'an Medical University (CN)
  • Shandong First Medical University (CN)
Corresponding author
Chi, Xiaohong
Venue
American Journal of Reproductive Immunology
Publisher
Wiley
Published
2024-08
Volume
92
Issue
2
Pages
e13864-e13864
ISSN
  • 0271-7352 (ISSN-L)
  • 1046-7408
  • 1600-0897
OpenAlex
W4401577208
Cited by
7
References
63
Citations by year
2026: 2 · 2025: 4 · 2024: 1
FWCI
2.02
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Reproductive Immunology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Ferroptosis and cancer prognosis
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Keywords
long non-coding RNA, ovarian cancer, ferroptosis, GPX4, CREB1, RNA-binding proteins, erastin, tumor progression, cell proliferation and invasion, prognosis
MeSH terms
Ferroptosis, Phospholipid Hydroperoxide Glutathione Peroxidase, Tumor Protein, Translationally-Controlled 1, Animals, Cell Movement, Female, Humans, Mice, Nude, Ovarian Neoplasms, Gene Expression Regulation, Neoplastic, Cyclic AMP Response Element-Binding Protein, Cell Line, Tumor, Cell Proliferation, Mice, RNA, Long Noncoding

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review